CompletedPhase 4NCT05244954

Comparing Chemoprevention Approaches for School-based Malaria Control

Studying Malaria

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Maryland, Baltimore
Principal Investigator
Lauren Cohee, MD MS
University of Maryland, Baltimore
Intervention
Dihydroartemisinin-Piperaquine(drug)
Enrollment
746 target
Eligibility
All sexes
Timeline
2022 – 2022

Study locations (1)

Collaborators

Kamuzu University of Health Sciences · Doris Duke Charitable Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05244954 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria →

← Back to all trials